Protara Therapeutics, Inc. Restructuring Charges
Protara Therapeutics, Inc. (TARA) reported Restructuring Charges of $2.85 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-20.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2020-03-20
- Protara Therapeutics, Inc. restructuring charges for the quarter ending 2019-12-31 was $0.00.
- Protara Therapeutics, Inc. restructuring charges for the quarter ending 2019-09-30 was -$46.00K.
- Protara Therapeutics, Inc. restructuring charges for fiscal 2019 was $2.85M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-20 | -$46.00K derived: sum of 2 quarters · filed 2020-03-20 | $2.85M 10-K · filed 2020-03-20 | |
| 2019-09-30 | -$46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $2.85M 10-Q · filed 2019-10-31 | ||
| 2019-06-30 | $2.90M 10-Q · filed 2019-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |